vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and UDR, Inc. (UDR). Click either name above to swap in a different company.
UDR, Inc. is the larger business by last-quarter revenue ($425.8M vs $284.0M, roughly 1.5× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 44.6%, a 51.8% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 0.9%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 1.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
UDR, Inc. is a leading U.S.-headquartered real estate investment trust specializing in owning, operating, and redeveloping high-quality multifamily residential apartment communities. It operates across major U.S. metropolitan markets, catering to a diverse tenant base including young professionals, families, and middle-to-high income households.
ACAD vs UDR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $425.8M |
| Net Profit | $273.6M | $189.8M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 54.0% |
| Net Margin | 96.3% | 44.6% |
| Revenue YoY | 9.4% | 0.9% |
| Net Profit YoY | 90.3% | 147.2% |
| EPS (diluted) | $1.61 | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $425.8M | ||
| Q4 25 | $284.0M | $433.1M | ||
| Q3 25 | $278.6M | $431.9M | ||
| Q2 25 | $264.6M | $425.4M | ||
| Q1 25 | $244.3M | $421.9M | ||
| Q4 24 | $259.6M | $422.7M | ||
| Q3 24 | $250.4M | $420.2M | ||
| Q2 24 | $242.0M | $415.3M |
| Q1 26 | — | $189.8M | ||
| Q4 25 | $273.6M | $222.9M | ||
| Q3 25 | $71.8M | $40.4M | ||
| Q2 25 | $26.7M | $37.7M | ||
| Q1 25 | $19.0M | $76.7M | ||
| Q4 24 | $143.7M | $-5.0M | ||
| Q3 24 | $32.8M | $22.6M | ||
| Q2 24 | $33.4M | $28.9M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | — | 54.0% | ||
| Q4 25 | 6.1% | 64.1% | ||
| Q3 25 | 12.8% | 17.7% | ||
| Q2 25 | 12.2% | 18.2% | ||
| Q1 25 | 7.9% | 29.0% | ||
| Q4 24 | 59.1% | 15.7% | ||
| Q3 24 | 12.6% | 16.6% | ||
| Q2 24 | 12.6% | 16.5% |
| Q1 26 | — | 44.6% | ||
| Q4 25 | 96.3% | 51.5% | ||
| Q3 25 | 25.8% | 9.4% | ||
| Q2 25 | 10.1% | 8.9% | ||
| Q1 25 | 7.8% | 18.2% | ||
| Q4 24 | 55.4% | -220.5% | ||
| Q3 24 | 13.1% | 5.4% | ||
| Q2 24 | 13.8% | 7.0% |
| Q1 26 | — | $0.63 | ||
| Q4 25 | $1.61 | $0.67 | ||
| Q3 25 | $0.42 | $0.12 | ||
| Q2 25 | $0.16 | $0.11 | ||
| Q1 25 | $0.11 | $0.23 | ||
| Q4 24 | $0.86 | $-0.01 | ||
| Q3 24 | $0.20 | $0.06 | ||
| Q2 24 | $0.20 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $1.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $3.3B |
| Total Assets | $1.6B | $10.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.3M | ||
| Q4 25 | $177.7M | $1.2M | ||
| Q3 25 | $258.0M | $1.2M | ||
| Q2 25 | $253.6M | $1.5M | ||
| Q1 25 | $217.7M | $1.3M | ||
| Q4 24 | $319.6M | $1.3M | ||
| Q3 24 | $155.1M | $2.3M | ||
| Q2 24 | $177.1M | $2.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $5.8B | ||
| Q3 25 | — | $5.8B | ||
| Q2 25 | — | $5.8B | ||
| Q1 25 | — | $5.8B | ||
| Q4 24 | — | $5.8B | ||
| Q3 24 | — | $5.9B | ||
| Q2 24 | — | $5.8B |
| Q1 26 | — | $3.3B | ||
| Q4 25 | $1.2B | $3.3B | ||
| Q3 25 | $917.3M | $3.3B | ||
| Q2 25 | $822.4M | $3.3B | ||
| Q1 25 | $765.2M | $3.3B | ||
| Q4 24 | $732.8M | $3.4B | ||
| Q3 24 | $577.2M | $3.5B | ||
| Q2 24 | $516.7M | $3.7B |
| Q1 26 | — | $10.3B | ||
| Q4 25 | $1.6B | $10.6B | ||
| Q3 25 | $1.3B | $10.6B | ||
| Q2 25 | $1.2B | $10.6B | ||
| Q1 25 | $1.1B | $10.7B | ||
| Q4 24 | $1.2B | $10.9B | ||
| Q3 24 | $976.9M | $11.1B | ||
| Q2 24 | $914.1M | $11.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.77× | ||
| Q3 25 | — | 1.78× | ||
| Q2 25 | — | 1.74× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | 1.69× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | — | 1.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 4.9% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $902.9M | ||
| Q3 25 | $74.3M | $234.9M | ||
| Q2 25 | $64.0M | $250.3M | ||
| Q1 25 | $20.3M | $156.2M | ||
| Q4 24 | $40.4M | $876.8M | ||
| Q3 24 | $63.2M | $230.3M | ||
| Q2 24 | $25.0M | $238.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $650.0M | ||
| Q3 25 | $73.9M | $164.6M | ||
| Q2 25 | — | $190.1M | ||
| Q1 25 | — | $103.2M | ||
| Q4 24 | — | $627.0M | ||
| Q3 24 | $63.2M | $161.3M | ||
| Q2 24 | — | $171.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 150.1% | ||
| Q3 25 | 26.5% | 38.1% | ||
| Q2 25 | — | 44.7% | ||
| Q1 25 | — | 24.5% | ||
| Q4 24 | — | 148.3% | ||
| Q3 24 | 25.2% | 38.4% | ||
| Q2 24 | — | 41.2% |
| Q1 26 | — | 4.9% | ||
| Q4 25 | — | 58.4% | ||
| Q3 25 | 0.1% | 16.3% | ||
| Q2 25 | — | 14.2% | ||
| Q1 25 | — | 12.6% | ||
| Q4 24 | — | 59.1% | ||
| Q3 24 | 0.0% | 16.4% | ||
| Q2 24 | — | 16.2% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | 4.05× | ||
| Q3 25 | 1.03× | 5.81× | ||
| Q2 25 | 2.40× | 6.64× | ||
| Q1 25 | 1.07× | 2.04× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | 10.19× | ||
| Q2 24 | 0.75× | 8.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
UDR
| Rental income | $423.3M | 99% |
| Joint venture management and other fees | $2.5M | 1% |
